What is Bausch Health Companies's R&D?

Bausch Health Companies (BHC) reported R&D of $163M in Q1 2026.

How has Bausch Health Companies's R&D changed year-over-year?

Bausch Health Companies's R&D increased by 14.0% year-over-year, from $143M to $163M.

What is the long-term trend for Bausch Health Companies's R&D?

Over 4 years (2021 to 2025), Bausch Health Companies's R&D has grown at a 7.8% compound annual growth rate (CAGR), from $465M to $629M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Bausch Health Companies BHC R&D

R&D at other companies

Bausch + LombBLCO

$101M+17.4%

OrganonOGN

$93M-3.1%

HRO

HarrowHROW

$5.9M+94.8%

Neurocrine BiosciencesNBIX

$296.2M+12.5%

ViatrisVTRS

$248.6M+12.0%

Bristol-Myers SquibbBMY

$2.65B+17.4%

Segments

By segment

See full

Bausch + Lomb$45M+60.7%

Salix$19M+11.8%

Solta Medical$8M+60.0%

International$6M0.0%

Diversified$3M0.0%

Other financials

Income statement

See full

Revenue$2.5B+11.7%

Operating income-$950.0M-444%

Net income-$1.4B-2,353%

EPS (diluted)-$3.82-2,287%

Balance sheet

See full

Cash & equivalents$1.3B+13.4%

Total debt$20.8B-3.5%

Total equity-$2.1B-74.0%

Total assets$24.5B-7.3%

Cash flow

See full

Operating cash flow$230.0M+9.0%

CapEx$109.0M-5.2%

Free cash flow$121.0M+26.0%

Valuation

See full

Market cap$1.79B-15.9%

Enterprise value$21.24B-5.6%

P/S0.2×0.0×

Profitability

See full

Gross margin71.4%—

Operating margin5.6%-10.3pp

Net margin-1.9%-0.9pp

FCF margin9.8%-2.8pp

Returns & leverage

See full

Return on equity-70.1%—

Debt / equity45.2×—

Current ratio1.3×0.0×

Where this comes from

Reported directly by Bausch Health Companies in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost.

The official record: Bausch Health Companies’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Bausch Health Companies's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Bausch Health Companies's R&D?: Bausch Health Companies (BHC) reported R&D of $163M in Q1 2026.
How has Bausch Health Companies's R&D changed year-over-year?: Bausch Health Companies's R&D increased by 14.0% year-over-year, from $143M to $163M.
What is the long-term trend for Bausch Health Companies's R&D?: Over 4 years (2021 to 2025), Bausch Health Companies's R&D has grown at a 7.8% compound annual growth rate (CAGR), from $465M to $629M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.